Encore! EP337: A Patient-First Specialty Pharmacy, Not a Money-First Specialty Pharmacy, With Olivia Webb

A Patient-First Specialty Pharmacy, Not a Money-First Specialty Pharmacy, With Olivia Webb (Encore! EP337) In this Encore, Stacey Richter revisits her conversation with Olivia Webb, healthcare strategist and author of the Acute Condition newsletter, about why the specialty pharmacy model is built around the power struggle for revenue between providers, PBMs, insurers, and Pharma — with patients too often an afterthought. WHAT YOU'LL LEARN ✅ Why specialty drugs — often biologics, infusions, or cancer therapies — get routed outside traditional retail pharmacy ✅ Why patients frequently can't get a straight answer about the six-figure therapy they're about to receive ✅ What a "patient-first specialty pharmacy" would actually look like, and why the incentives currently work against it ✅ Why the time may be ripe for disruption as lawsuits target PBM/insurer/specialty pharmacy vertical integration ✅ Why scale is required for any new entrant trying to build a better specialty pharmacy model WHY THIS MATTERS Specialty pharmacy is a battlefield between providers, PBMs, insurers, and Pharma over revenue and captive patient populations — and the patient, despite carrying the financial and clinical stakes, is rarely centered in that fight. Building a genuinely patient-first specialty pharmacy means confronting a system with no clear incentive to cap prices or prioritize the person actually receiving the drug. MENTIONED IN THIS EPISODE AEE15 with David Carmouche, MD: Apple Podcasts | Spotify | Other Apps (link unavailable) === LINKS === 🔗 Show Notes with all mentioned links: Episode Page ✉️ Enjoy this podcast? Subscribe to the free weekly newsletter 🫙 Support the podcast with a small donation to the Tip Jar 📺 Subscribe to our YouTube channel 🎤 Listen on Apple Podcasts 🎤 Listen on Spotify === CONNECT WITH THE RHV TEAM === ✭ LinkedIn ✭ Threads ✭ Bluesky ✭ X 00:00 Introduction 04:43 Why did Olivia start thinking about a patient-centric specialty pharmacy? 06:05 "There's really no layer on top of it to make it look nice." 06:55 "You're kind of dealing with this vertical stack that doesn't really deal with patients frequently." 07:07 Is the specialty model more patient friendly or less? 07:39 What would a patient-centric specialty pharmacy look like? 08:29 "There's a lot of fragmentation; there's a lot of friction." 08:42 What's unique to specialty pharmacy prescriptions? 11:09 Why can infusion centers be a high-drama place? 12:44 What's "the question" around specialty pharmacy? 13:11 Who has the vested interest in ensuring patients take their medications correctly in specialty pharmacy? 15:08 "It's really just a unique area of healthcare where the people that I think of as the good guys and the bad guys completely flips." 16:34 Why might the time be ripe for disruption in the specialty pharmacy area? 20:26 "There's no one with a clear incentive to cap the prices." 20:39 What are the barriers in specialty pharmacy? 21:01 "The patient just isn't at the center, the financial incentive, in any direction." 29:44 "I think people who are designing these things need to see how patients are actually doing it." 30:13 "I think there's a lot of money here; I think this market is going to only increase in size." 30:32 "I think you need scale." 30:42 AEE15 with David Carmouche, MD, of Ochsner.